Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
How to identify animal tracks, burrows and other signs of wildlife in your neighborhood- Peruvian ex-President Martin Vizcarra sentenced to 14 years in prison
- Support Your Body: A Manual for Smart dieting and Sustenance
- Lucky airplane passengers capture NASA's Artemis 2 moon launch from the sky
- Analysis-NASA's moon mission tests aerospace old guard as SpaceX, Blue Origin hover
- The Leonid meteor shower is peaking early this week. Here’s what to know
- Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
- Reporter's notebook: Inside the IDF’s ‘Hamas Village,’ and how Israel is rewriting urban warfare
- ‘This year nearly broke me as a scientist’ – US researchers reflect on how 2025’s science cuts have changed their lives
